Jane Wainright

Partner Potter Clarkson

Jane read genetics at the University of Wales, Swansea, choosing to specialise in the areas of human disease genetics and gene therapy technologies. Jane was awarded the Genetics Prize for the highest finals examination marks. Prior to realising that her career path lay in the patent profession, Jane spent two years studying medicine at Oxford University. Jane joined Potter Clarkson in 2001 and became a partner in 2011. Jane has continued to work in the field of biotechnology and deals with subjects including recombinant technology, antibody therapies, drug screening assays and gene therapy technologies. She also handles patent applications in a number of biotechnology and chemistry cross-over areas, in particular combined chemical-biotechnology assays for biological sample assessment and the biological production of modified chemical compounds. Jane provides commercially relevant advice tailored to the needs and commercial goals of each client, be they a University, SME or multinational corporation. Jane regularly advises her clients on all aspects of filing and prosecution strategy, as well as third party issues such as oppositions, third party observations and due diligence investigations. In particular, she has considerable experience planning worldwide patenting strategies and co-ordinating their implementation before numerous patent offices, as well as directly representing clients at the European Patent Office. Jane has been involved in a number of due diligence projects relating to company and IP acquisitions (for both acquirer and acquiree).